Iradimed Corporation (IRMD 13.04%), a medical device maker specializing in MRI-compatible infusion pumps and patient monitoring systems, reported its second quarter 2025 earnings on August 1, 2025. The headline news was another round of record revenue and profit, with revenue of $20.41 million and non-GAAP earnings per share of $0.49. These results comfortably topped analyst forecasts, which had called for $20.01 million in revenue and $0.435 in non-GAAP EPS. Compared to the guidance issued last quarter, bo ...